Related Experiment Videos

D1 antagonist in clinical trial

Trends in Pharmacological Sciences

|May 1, 1990

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

SCH 39166, a potential antipsychotic drug, does not evoke movement disorders in cebus monkeys.

Neurochemistry international·1992

Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.

European journal of pharmacology·1992

Selective up-regulation of D-1 dopamine receptors following chronic administration of SCH 39166 in primates.

Pharmacology, biochemistry, and behavior·1992

[3H]SCH 39166, a new D1-selective radioligand: in vitro and in vivo binding analyses.

Journal of neurochemistry·1991

In vivo binding of SCH 39166: a D-1 selective antagonist.

The Journal of pharmacology and experimental therapeutics·1991

Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates.

The Journal of pharmacology and experimental therapeutics·1991

See all related articles